Company record
Beta Bionics, Inc.
1 FDA warning letter since 2023 and 3 recalls in the last 12 months.
Get an email the day FDA posts anything new about Beta Bionics, Inc..
Warning letters
-
DevicesBeta Bionics, Inc.
FDA says Beta Bionics' iLet Bionic Pancreas system had quality-system failures, including ignored complaints of severe hypoglycemia and diabetic ketoacidosis.
High risk
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Jun 24 | Class II | Beta Bionics, Inc. Device |
iLet Bionic Pancreas, REF: BB1001 The reason for the recall is: it was found in version 3.3.6 of the iLet ACE Pump firmware and all previous releases that a screen unlock failure could occur when the user successfully slides the unlock slider on the Lock Screen, no screen transition occurs, and the user remains on the Lock Screen. Because the user cannot exit the Lock Screen, the user is unable to perform a cartridge change or meal announcement. If this occurs and therapy is in progress, therapy will continue normally until the insulin cartridge is depleted. The user will be unable to perform a cartridge change or a meal announcement and will be stuck on the screen until the battery fully drains. This can lead to hyperglycemia. |
| May 6 | Class II | Beta Bionics, Inc. Device |
iLet Bionic Pancreas, REF: BB1001 insulin pump software versions 1.4.2, and 1.4.3 issue with Dexcom Continuous Glucose Monitoring (CGM) G7 sensor may result in delayed CGM reading then switch to non-CGM dosing, leading to only basal/requested meal doses provided, no correction doses/insulin reductions/suspensions for high/low glucose unless blood glucose entered for sensor life or replacement. Potential health risks to users include severe hyperglycemia with and without DKA and severe hypoglycemia. |
| Apr 22 | Class II | Beta Bionics, Inc. Device |
iLet Ace Pump Kit REF: BB1001 iLet Dosing Decision Software it was found that in versions 1.3.7, 1.4.2, and 1.4.3, the Lock Screen and Limited Access Passcode Screen on the iLet graphical user interface (GUI) include certain icons displayed in the status bar that are active, thereby allowing the user to bypass those screens when those icons on the status bar are pressed, allowing unauthorized access while the device is in Limited Access Mode. A Health Risk associated with Limited access mode includes severe hypoglycemia due to unauthorized access to the iLet if someone were to make unauthorized meal announcements or stopped insulin delivery. |